1- MD, Assistant Professor of Infectious Diseases, Fellowship in IC host & transplant, Department of Infectious Diseases and Tropical Medicine, Faculty of Medicine, Mashhad University of Sciences, Mashhad, Iran
2- Resident, Department of Infectious Diseases and Tropical Medicine, Faculty of Medicine, Mashhad University of Sciences, Mashhad, Iran
3- MD, Assistant Professor of Rheumatology, Rheumatic Diseases Research Center, Mashhad University of Medical Sciences, Mashhad, Iran , mkhodashahi53@gmail.com
Abstract: (1430 Views)
Introduction: Mucormycosis is a rare, progressive, and dangerous fungal infection with a high mortality rate. There have been several reports of increased mucormycosis rate during the COVID-19 pandemic.
Case Presentation: Here, we report a 69 years old men of sinoorbital mucormycosis as a late complication of COVID-19. Endoscopic sinus surgery was performed underwent general anesthesia and all necrotic tissues were removed. Nasal biopsy showed inflammatory and necrotic tissue, fungal infestation along with mucormycosis and aspergillus.
Conclusions: It seems that diabetes, improper use of corticosteroids, and COVID-19 are the three key causes of increased incidence of mucormycosis. Therefore, further research is warranted for the improved evaluation, prevention, and management of opportunistic infections in these patients. Also, the use of immunosuppressants should be accompanied by perfect supervision.
Type of Study:
Case Report |
Subject:
Basic Sciences Received: 2021/12/22 | Accepted: 2022/01/22 | Published: 2022/03/1